Patents Examined by Erik B Crawford
-
Patent number: 10180428Abstract: There is disclosed a system for electrical charge detection comprising a nanoFET device. Also disclosed is a method of electrical charge detection for single molecule sequencing. The method includes attaching a macromolecule or assemblies thereof to a gate of a nanoFET device and flowing in a solution of charge tags, where a charge tag includes a nucleotide attached to a charge complex. The method also includes incorporating one charge tag into the macromolecule or assemblies thereof and cleaving the charge tags from the macromolecule or assemblies thereof. The method further includes detecting at least one of current and voltage from the nanoFET device.Type: GrantFiled: September 24, 2015Date of Patent: January 15, 2019Assignee: APPLIED BIOSYSTEMS, LLCInventors: Mark F. Oldham, Eric S. Nordman
-
Patent number: 10168292Abstract: An article comprising: an array of calorimeter devices, wherein the device comprises: at least one fluidic enclosure disposed on a microfluidic chip, wherein the fluidic enclosure is substantially gas impermeable; at least one first chamber and at least one second chamber, wherein the first chamber and the second chamber are disposed within and enclosed by the fluidic enclosure, wherein the first chamber and the second chamber are not vacuum encapsulated; at least two microfluidic channels connected to the first chamber and at least two microfluidic channels connected to the second chamber; and at least one thermal sensor disposed between the chip and the first and second chambers, wherein the thermal sensor is adapted to measure a temperature differential between the first and second chambers. Examples include DSC and TSA devices. Biological binding and melting experiments can be done with high sensitivity.Type: GrantFiled: March 15, 2013Date of Patent: January 1, 2019Assignee: CALIFORNIA INSTITUTE OF TECHNOLOGYInventors: Chung Wah Fon, Michael L. Roukes
-
Patent number: 10168324Abstract: The present invention relates to a test system or an assay system (detection system) and test method preferably for use in the Point-of-Care (PoC) field.Type: GrantFiled: February 19, 2014Date of Patent: January 1, 2019Assignee: DST DIAGNOSTISCHE SYSTEME & TECHNOLOGIEN GMBHInventors: Marc Dangers, René Rübenhagen
-
Patent number: 10161927Abstract: Among others, the present invention provides apparatus for detecting a disease, comprising a system delivery biological subject and a probing and detecting device, wherein the probing and detecting device includes a first micro-device and a first substrate supporting the first micro-device, the first micro-device contacts a biologic material to be detected and is capable of measuring at the microscopic level an electric, magnetic, electromagnetic, thermal, optical, acoustical, biological, chemical, physical, or mechanical property of the biologic material.Type: GrantFiled: June 30, 2011Date of Patent: December 25, 2018Assignee: AnPac Bio-Medical Science Co., Ltd.Inventors: Chris C Yu, He Yu, Xuedong Du
-
Patent number: 10156568Abstract: Techniques for detection of virus-antibody nanocomplexes using a chip-based pillar array are provided. In one aspect, a method for virus detection is provided. The method includes the steps of: collecting a fluid sample from a virus-bearing source; contacting the fluid sample with an antibody that binds to viruses to form a sample-antibody mixture, wherein the antibody is labeled with a fluorescent tag; separating particles including any antibody-virus complexes, if present, from the sample-antibody mixture using an assay nanopillar array; and detecting the antibody-virus complexes, if present, in the particles from the separating step using fluorescence. A virus detection chip device and a chip-based immunoassay method are also provided.Type: GrantFiled: April 30, 2015Date of Patent: December 18, 2018Assignee: International Business Machines CorporationInventors: Yann Astier, Stacey M. Gifford, Benjamin H. Wunsch
-
Patent number: 10151747Abstract: A problem to be solved by the present invention is to provide an immunochromatographic test strip and a detection method using immunochromatography avoiding aggregation of colloidal gold conjugates while red blood cells in whole blood are agglutinated and then separated and removed in the case of using polybrene as a blood-agglutinating agent and the colloidal gold conjugates as a detection reagent. To solve the problem, the present inventers reviewed a past reagent configuration itself from a completely different viewpoint rather than selecting type and amount of polyanions and, as a result of extensive study on each element, the inventers surprisingly found that aggregation of colloidal gold can be suppressed by using a certain buffer solution without using neutralization by polyanions.Type: GrantFiled: December 22, 2016Date of Patent: December 11, 2018Assignee: Sekisui Medical Co., Ltd.Inventors: Mayumi Yoshida, Mitsuaki Yamamoto, Shinya Yokokawa, Tomo Shimizu, Keigo Kono
-
Patent number: 10137426Abstract: Screening assays and methods of performing such assays are provided. In certain examples, the assays and methods may be designed to determine whether or not two or more species can associate with each other. In some examples, the assays and methods may be used to determine if a known antigen binds to an unknown monoclonal antibody.Type: GrantFiled: September 16, 2016Date of Patent: November 27, 2018Assignee: President and Fellows of Harvard CollegeInventors: J. Christopher Love, Hidde L. Ploegh, Jehnna Ronan
-
Patent number: 10139416Abstract: Methods are disclosed for performing a bioassay, comprising activating capsules containing a signal precursor that is hydrolysable from a latent form in which substantially no signal is generated to a form in which it is able to generate a detectable signal, said activating comprising treating said capsules with heat and with an acid or a base catalyzing solution, the combination of said heat and the pH of the catalyzing solution being such as to hydrolyze said precursor to the form in which it is able to generate a detectable signal.Type: GrantFiled: August 30, 2012Date of Patent: November 27, 2018Assignee: SUPERNOVA DIAGNOSTICS INC.Inventors: Neil J. Campbell, Keith Edward Moravick
-
Patent number: 10130946Abstract: This disclosure provides a system for detecting rare cells. The system includes a substrate, extensions extending outwardly from the substrate and arranged about a center axis of the substrate to define a channel enabling the fluid to move radially from the center axis to an outer edge of the substrate, and a functionalized graphene oxide disposed on the extension. This disclosure also provides a method for detecting rare cells using the system of this disclosure. The method includes the steps of introducing a sample of fluid containing the rare cells into the inlet of the system such that the sample of fluid flows radially from the inlet toward the outer edge of the substrate and capturing the rare cells as the rare cells interact with the functionalized graphene oxide disposed on the extensions.Type: GrantFiled: April 6, 2015Date of Patent: November 20, 2018Assignee: THE REGENTS OF THE UNIVERSITY OF MICHIGANInventors: Sunitha Nagrath, Vasudha Murlidhar
-
Patent number: 10130949Abstract: The present invention concerns a microfluidic system comprising: a microchannel containing several elements of two non-miscible fluids, the microchannel comprising a droplet (30) containing magnetic particles (M), and a device for generating inside the microchannel magnetic field, said device comprising an activable magnetic element, the activable magnetic element comprising a tip (5,6), the microfluidic system being configured to transport the droplet by flow or by pressure difference.Type: GrantFiled: July 24, 2012Date of Patent: November 20, 2018Assignees: SORBONNE UNIVERSITE, CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE, ETAT FRANCAIS REPRESENTED BY MINISTERE DE LA DEFENSEInventors: Jean-Louis Viovy, Laurent Malaquin, Stefano Begolo, Anaïs Ali Cherif, Stephanie Descroix
-
Patent number: 10126291Abstract: The present invention provides, among others, apparatus for detecting a disease, comprising a system delivery biological subject and a probing and detecting device, wherein the probing and detecting device includes a first micro-device and a first substrate supporting the first micro-device, the first micro-device contacts a biologic material to be detected and is capable of measuring at the microscopic level an electric, magnetic, electromagnetic, thermal, optical, acoustical, biological, chemical, physical, or mechanical property of the biologic material.Type: GrantFiled: April 4, 2013Date of Patent: November 13, 2018Assignee: AnPac Bio-Medical Science Co., Ltd.Inventors: Chris C Yu, Xuedong Du, He Yu
-
Patent number: 10114015Abstract: The present invention is directed to methods for reducing cross-reactivity between species employed in multiplexed immunoassays.Type: GrantFiled: March 13, 2014Date of Patent: October 30, 2018Assignee: MESO SCALE TECHNOLOGIES, LLC.Inventors: Eli N. Glezer, John Kenten
-
Patent number: 10088477Abstract: Described here are a device and a method for detecting the presence of a biomarker using the device, wherein the device comprises (a) a substrate comprising a plurality of electrodes; (b) a plurality of nanowire field-effect transistor sensors integrated or assembled on the substrate and connected to the electrodes; and (c) a microfluidic component disposed on the substrate and adapted to communicate fluidically with the nwFET sensors.Type: GrantFiled: July 30, 2013Date of Patent: October 2, 2018Assignee: The Regents of the University of CaliforniaInventor: Chi On Chui
-
Patent number: 10082502Abstract: An assay device includes: a detection zone which includes a first set of projections which are capable of generating capillary flow. A wicking zone (WZ) has a capacity to receive liquid sample flowing from the detection zone and includes a second set of projections which are capable of generating capillary flow. The WZ is rectangular in shape and the longer side of the rectangle extends in the direction of flow to thereby reduce the pressure gradient in the assay device which increases the total flow time of liquid sample compared to a WZ having equal length sides and same volume. At least a portion of the second set of projections have at least one dimension selected from a diameter, a center-to-center spacing, or a gap between projections that is different from the first set of projections, and is selected to increase the total flow time of the sample.Type: GrantFiled: February 5, 2016Date of Patent: September 25, 2018Assignee: ORTHO-CLINICAL DIAGNOSTICS, INC.Inventors: James D. Kanaley, Zhong Ding, Philip C. Hosimer, Edward R. Scalice, Susan Danielson, David A. Tomasso, Timothy C. Warren
-
Patent number: 10082504Abstract: The present disclosure provides an apparatus comprising an air circulating device, an allergen source comprising an allergen, and a housing. The housing can be collapsible, portable, disposable and configurable. The present disclosure also provides a method comprising positioning an allergen source comprising an allergen in a chamber, distributing at least a portion of the allergen from the allergen source within the chamber, and collecting at least a portion of the distributed allergen. In an embodiment, the level of the shed allergen can be used to measure the effectiveness of various measures implemented to reduce airborne Fel d1 that is emitted from soiled cat litter. In another embodiment, the allergen can be introduced at a desired level in the chamber, and the resultant symptoms of a subject (e.g. a human) within the chamber can be identified and correlated with the amount of allergen.Type: GrantFiled: November 17, 2015Date of Patent: September 25, 2018Assignee: Nestec S.A.Inventors: Richard Nelson, Ebenzer Satyaraj
-
Patent number: 10073086Abstract: The present invention concerns a device for analyzing biological parameters from a sample (6) comprising (i) first transferring means (5, 20, 25), (ii) first preparing means (7), (iii) means for measuring cellular components (8), (iv) second preparing means (10, 11, 22, 23, 24) capable of carrying out, on a sample from the first preparing means (7), at least one dilution with an assay reagent (R3) comprising particles functionalized at the surface with at least one ligand specific to at least one analyte of interest, (v) immunodetection measurement means (30, 31) capable of assaying at least one analyte of interest by measuring the aggregation of functionalized particles, said device further comprising (i) second transferring means (4, 21, 22, 26) at least partially separate from the first transferring means (5, 20, 25) and (ii) means for applying a magnetic field (28) capable of causing, by magnetic interaction, an acceleration of the aggregation of said functionalized particles, which comprise magnetic collType: GrantFiled: January 29, 2013Date of Patent: September 11, 2018Assignee: HORIBA ABX SASInventors: Jèrôme Bibette, Philippe Nerin, Jean-Philippe Gineys, Gilles Cauet
-
Patent number: 10067125Abstract: The invention relates to methods of reliably and quantitatively determining the amount of an analyte of interest in a fluid sample using a flow-induced assay, such as an immunochromatographic assay, in which spatiotemporal measurements are recorded during the course of the assay reaction, generating a spatiotemporal dataset, and subsequently analyzed. The invention also relates to a system incorporating instruments for recording spatiotemporal datasets (spatiotemporal data recorders), devices comprised of flow-induced assays configured for analysis on a spatiotemporal recorder, and programs for analyzing the recorded spatiotemporal datasets.Type: GrantFiled: September 4, 2013Date of Patent: September 4, 2018Inventor: Edward L Mamenta
-
Patent number: 10067123Abstract: This invention is in the field of medical devices. Specifically, the present invention provides portable medical devices that allow real-time detection of analytes from a biological fluid. The methods and devices are particularly useful for providing point-of-care testing for a variety of medical applications. In particular, the medical device reduces interference with an optical signal which is indicative of the presence of an analyte in a bodily sample.Type: GrantFiled: June 11, 2013Date of Patent: September 4, 2018Assignee: Theranos IP Company LLCInventors: Ian Gibbons, Michael O'Connell
-
Patent number: 10058276Abstract: Techniques for monitoring a target analyte in a sample using a polymer capable of binding to the target analyte are disclosed. An implantable monitor useful for the disclosed techniques includes a microdevice coupled with a wireless interface. The wireless interface can comprise a capacitance digital converter coupled with the microdevice and can be adapted to produce a digital signal representing a measurement of the target analyte. A microcontroller can be coupled with the capacitance digital converter and a transponder can be coupled with the microcontroller to transmit the digital signal received from the capacitance digital converter to an external reader.Type: GrantFiled: May 13, 2016Date of Patent: August 28, 2018Assignee: THE TRUSTEES OF COLUMBIA UNIVERSITY IN THE CITY OF NEW YORKInventors: Qiao Lin, Xian Huang
-
Patent number: 10054584Abstract: Devices and methods for performing a point of care diagnostic test for detecting and quantifying at least one analyte in a biological sample. The device may include an immunoassay apparatus and a holder with a variable angle stage for positioning the immunoassay apparatus relative to a light source and a detector device. In one embodiment, the device is based upon elastic light scattering, so the variation in the angle of incidence and angle of reflection are optimized to maximize signal generation due to elastic light scattering. The detector device may include a wired or wireless connection to a computer network for communicating with an electronic medical records system, uploading the amount or concentration of at least one analyte present in the sample to the electronic medical records system, or querying a decision support algorithm stored in a computer readable format. The detector device may further include an onboard interpretive algorithm.Type: GrantFiled: November 1, 2013Date of Patent: August 21, 2018Assignee: I-CALQ, LLCInventors: Joel R. L. Ehrenkranz, Pamela J. Turbeville, Jeong-Yeol Yoon, David J. You